MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo

Nature Immunology

Volumn 3, Issue 6, 2002, Pages 529-535

  Krmpotić, Astrid ^a   Busch, Dirk H ^b   Bubić, Ivan ^a   Gebhardt, Friedemann ^b   Hengel, Hartmut ^c   Hasan, Milena ^a   Scalzo, Anthony A ^d   Koszinowski, Ulrich H ^e   Jonjiić, Stipan ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GLYCOPROTEIN GP 40; GLYCOPROTEIN GP 48; LECTIN RECEPTOR; LIGAND; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN H 60; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE DELETION; GENETIC CODE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERTANT; VIRUS GENE; VIRUS MUTANT; VIRUS RESISTANCE;

ANIMALS; ANIMALS, CONGENIC; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE DELETION; GENES, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; RECEPTORS, IMMUNOLOGIC; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 0036076509     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni799     Document Type: Article

References (51)

1. Viral mechanisms of immune evasion
2. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus
3. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs
4. Hierarchical and redundant lymphocyte subset control precludes cytomagalovirus replication during latent infection
5. Viral subversion of the immune system
6. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: M4 and m152 inhibit antigen presentation in a complementary and cooperative fashion
7. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface
8. A cytomegalovirus glycoprotein re-routes MHC class 1 complexes to lysosomes for degradation
9. A mouse cytomegalovirus glycoprotein retains MHC class 1 complexes in the ERGIC/cls-Golgi compartments
10. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo
11. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen
12. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection
13. Genetic mapping of CmvI in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1
14. The natural killer gene complex: A genetic basis for understanding natural killer cell function and innate immunity
15. A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6
16. The effect of the Cmv-I resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells
17. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily
18. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H
19. Vital involvement of a natural killer cell activation receptor in resistance to viral infection
20. Strategies for target cell recognition by natural killer cells
21. Human natural killer cell receptors and co-receptors
22. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
23. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
24. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A
25. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
26. Costimulation of CD8αβT cells by NKG2D via engagement by MIC induced on virus-infected cells
27. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
28. The molecular and functional characterization of a dominant minor H antigen, H60
29. Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and γ interferon production and NK cell activation
30. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein
31. The BALB.B6-Cmvlr mouse: A strain congenic for Cmvl and the NK gene complex
32. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci
33. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment
34. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules
35. Strategies for the identification analysis of viral immune evasion genes: Cytomegalovirus as example
36. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
37. An activating immunoreceptor complex formed by NKG2D and DAP10
38. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity
39. Ectopic expression of retinoic acid early inducible-I gene (RAE-I) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
40. Regulation of Cutaneous Malignancy by γδT Cells
41. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions
42. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
43. The class I MHC homologue of human cytomegalovirus inhibits attach by natural killer cells
44. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
45. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis
46. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control
47. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
48. Establishment of monoclonal anti-Nk-1.1 antibody
49. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli
50. Coordinate regulation of complex T cell populations responding to bacterial infection